Quick Answer
- • As little as $25/month, any dose
- • Covers up to a 3-month prescription
- • Capped at $100/month in savings
- • Government beneficiaries excluded
- • Pill: $149 / $199 / $299 per month
- • Pen: $199 intro, then $349-$499
- • Through NovoCare Pharmacy
- • Pen offer stated as limited-time
Prices as published by Novo Nordisk on August 21, 2026. Eligibility and restrictions apply. Confirm the current price before you fill.
The Bottom Line
- • You have commercial or employer drug coverage
- • Your plan already covers Ozempic
- • Your remaining cost is under ~$125/month
- • You have no drug coverage at all
- • You're on Medicare, Medicaid, VA, or TRICARE
- • Your plan denied Ozempic or requires a step you can't clear
What We'll Cover
Ozempic pricing confuses people because there are four different numbers in circulation and they describe four different situations. There is the list price, which almost nobody pays. There is the savings-card price, which requires commercial insurance. There is the manufacturer's self-pay price, which is for people without coverage. And there is whatever your specific plan decides your copay is. Below, each number, with the published fine print that changes what it means.
Ozempic's List Price
NovoCare publishes a list price of $1,027.51 per package, and it is the same figure across every form and strength:
| Product | Package | List price |
|---|---|---|
| Ozempic pen, 0.25 or 0.5 mg | 1 x 1.5-mL pen | $1,027.51 |
| Ozempic pen, 1 mg | 1 x 3-mL pen | $1,027.51 |
| Ozempic pen, 2 mg | 1 x 3-mL pen | $1,027.51 |
| Ozempic pill, 1.5 mg | 1 bottle of 30 tablets | $1,027.51 |
| Ozempic pill, 4 mg | 1 bottle of 30 tablets | $1,027.51 |
| Ozempic pill, 9 mg | 1 bottle of 30 tablets | $1,027.51 |
Novo Nordisk defines list price as "the original price set for a medication by a manufacturer before any discounts or rebates are applied," and states plainly that "most people don't pay list price if they have health insurance." Treat it as the sticker on the windshield, not the transaction price.
One honest wrinkle
NovoCare's list-price page renders $1,027.51 in its desktop layout and $997.58 for those same packages in its mobile layout — the two blocks were not updated together. We report the desktop figure and flag the discrepancy rather than quietly picking one. Either way, the practical takeaway is unchanged: Ozempic's list price is roughly $1,000 per month, and the savings-card or self-pay price is the number that actually applies to you.
The Ozempic Savings Card: the $25 Number and Its Cap
Novo Nordisk advertises that eligible commercially insured patients "pay as little as $25" for any dose of Ozempic — pen or pill — for up to a 3-month prescription. That is the headline everyone quotes. The sentence immediately after it is the one that matters: savings are subject to a maximum of $100 per month.
What the $100 cap means in practice: the card absorbs up to $100 of your monthly cost. If your plan leaves you owing $120, the card takes you to about $25. If your plan leaves you owing $400 — because you are in a deductible phase, for instance — the card takes $100 off and you pay the rest. "As little as $25" is a floor, not a flat rate.
Novo Nordisk defines one month as one box containing one Ozempic pen, or one bottle of 30 tablets of the Ozempic pill. The company also reserves the right to modify or cancel the program at any time, and directs patients to the full terms at SavingsCardEligibility.com.
Who Actually Qualifies
The published eligibility rules are more specific than most summaries suggest, and a few of the carve-outs cut in patients' favor. Straight from Novo Nordisk's savings page:
- Commercial insurance is required for the $25 offer, along with a valid prescription.
- Government beneficiaries are excluded. Medicare, Medigap, VA, DoD, TRICARE, Medicaid, and other state or federal medical or pharmaceutical benefit programs all disqualify you from the card.
- Dual enrollment counts as government. Novo Nordisk states that individuals with both commercial and government-funded plans "ARE considered patients with government insurance."
- Three plan types are explicitly NOT government programs for purposes of this offer: the Federal Employees Health Benefits (FEHB) Program, Affordable Care Act health exchange plans, and insurance provided through state employee plans. If you are on one of those, you are not excluded.
- Excluded patients are not out of options. Novo Nordisk states that patients enrolled in government programs "are able to pay the self-pay price for their prescription."
The part that surprises people
The savings offer "operates outside of any third-party insurance." Novo Nordisk states that the money spent and the discounts you receive will not count toward your deductible or out-of-pocket requirements and cannot be submitted to your insurer for reimbursement. If you were counting on a high-cost prescription to burn down your deductible, the card changes that math.
Self-Pay Pricing Without Insurance
For uninsured and self-pay patients, Novo Nordisk sells directly through NovoCare Pharmacy at published per-dose prices. These are the numbers that answer "what does Ozempic cost without insurance," and they are nowhere near the list price:
| Form & dose | Self-pay price | Who it applies to |
|---|---|---|
| Pill, 1.5 mg | $149 / month | New patients (starting dose) |
| Pill, 4 mg | $199 / month | Existing patients |
| Pill, 9 mg | $299 / month | Existing patients |
| Pen, 0.25 mg or 0.5 mg | $199 / month | First 2 fills, patients new to the offer |
| Pen, 0.25 / 0.5 / 1 mg | $349 / month | After the intro period |
| Pen, 2 mg | $499 / month | Existing patients, highest pen dose |
The pen's $199 introductory price covers two monthly fills of the 0.25 mg and 0.5 mg starting doses for patients new to the Ozempic Savings Offer or NovoCare Pharmacy. Novo Nordisk labels it a limited-time offer good for two monthly fills through December 31, 2026, with pricing "to be updated" after that date. Plan on the steady-state numbers ($349 or $499), not the intro price, when you budget past the first two months.
If you cannot afford any of these
Novo Nordisk runs a Patient Assistance Program that, per NovoCare, "provides free medicine to those who qualify without any registration or monthly fees." It is income- and coverage-tested and requires an application, but it is a real published route and it is worth checking before you assume the drug is out of reach.
The Pill Is Cheaper Than the Pen
This is new, and it is the single most useful cost fact on this page. Ozempic tablets (1.5 mg, 4 mg, 9 mg) became available in the US for adults with type 2 diabetes on May 4, 2026 — per Novo Nordisk, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes. At self-pay, the pill starts at $149/month against the pen's $349/month steady-state price.
Two things to keep straight. First, the Ozempic pill and Rybelsus share an FDA label — both are oral semaglutide for type 2 diabetes — but the label states they are "not substitutable on a mg-to-mg basis." A 9 mg Ozempic tablet is not a 9 mg Rybelsus tablet. Second, the pill and the pen are different products with different dosing, and which one is appropriate is a clinical decision, not a budgeting one. Bring the price difference to your prescriber; do not act on it alone.
Insurance Reality for a Diabetes Drug
Ozempic is a type 2 diabetes medication, and that shapes everything about how plans treat it. Per its FDA label, Ozempic is indicated to improve glycemic control in adults with type 2 diabetes, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.
Practically, that means coverage decisions tend to hinge on your diagnosis, and prior authorization is common. Novo Nordisk runs a coverage checker on NovoCare that reports whether your plan covers Ozempic and gives an estimated cost — a faster answer than a formulary PDF. Two rules of thumb before you shop:
- Check coverage before you price-shop. If your plan covers Ozempic and the savings card applies, that path usually beats self-pay.
- Run the deductible math. Early in a plan year, a covered drug can still cost you full freight until the deductible is met — and card savings do not count toward it. Compare that real number against the $149-$499 self-pay price rather than assuming coverage wins.
If You Want It for Weight Loss, Read This
A large share of Ozempic price searches come from people who want it for weight loss. The honest answer changes the shopping list: no Ozempic product is FDA-approved for weight management. Not the pen, not the pill. Prescribing Ozempic for weight loss is off-label — legal for a clinician to do, but it means you are outside the indication that coverage, savings-card terms, and pharmacy programs are built around.
The on-label product is Wegovy, the same molecule (semaglutide) from the same manufacturer, dosed for weight management. Per its FDA label, Wegovy is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients 12 and older with obesity, and in adults with overweight plus at least one weight-related comorbid condition. It also carries a cardiovascular indication and a noncirrhotic MASH indication.
Why this matters for your wallet: Wegovy has its own NovoCare self-pay pricing and its own savings terms. If weight management is your goal, pricing Ozempic is pricing the wrong product. Start with our Wegovy cost guide instead, and bring the indication question to a licensed clinician.
If you are still weighing whether semaglutide is right for you at all, our Ozempic and semaglutide side effects guide reads the adverse-reaction rates straight off the FDA label, and Ozempic alternatives covers the other approved options and what they cost.
Cheaper Routes to Semaglutide
Brand Ozempic through NovoCare is one lane. There are others, each with a different tradeoff between price, convenience, and regulatory footing:
- The Ozempic pill at $149/month is the lowest published brand-Ozempic price. If a tablet is clinically appropriate for you, it is the cheapest on-label route.
- Cash-pay clinic programs bundle the medication, visits, and sometimes labs into one monthly fee. See our semaglutide cost guide for verified per-clinic prices, and the cheapest way to get semaglutide for the full route comparison.
- Compounded semaglutide is a separate and now heavily restricted market. Read compounded semaglutide before you consider it.
- Other GLP-1s may price better for your situation — compare across the class in cheapest GLP-1 without insurance and the full GLP-1 medications list.
Compare prices and clinics
- Weight-loss clinics by state: browse the GLP-1 and weight-loss clinic directory
- Cross-service pricing: see the cash-pay price index
Compare GLP-1 Prices in One Place
Verified cash-pay prices across semaglutide and tirzepatide programs, quoted from the clinics' own sites and dated.
Browse Weight-Loss ClinicsFrequently Asked Questions
How much does Ozempic cost without insurance?▼
Without insurance, the published route is Novo Nordisk's self-pay pricing through NovoCare Pharmacy rather than the list price. As published in August 2026, the Ozempic pill starts at $149 per month for the 1.5 mg dose, $199 per month for 4 mg, and $299 per month for 9 mg. The Ozempic pen is $199 per month for the first two months of 0.25 mg or 0.5 mg for patients new to the offer, then $349 per month for 0.25 mg, 0.5 mg, or 1 mg, and $499 per month for 2 mg. The list price for comparison is $1,027.51 per package. Novo Nordisk labels the self-pay pen offer a limited-time offer with pricing to be updated after December 31, 2026, so confirm the current number at NovoCare before you fill.
How much is Ozempic with the savings card?▼
Novo Nordisk advertises that eligible patients with commercial insurance may pay as little as $25 for any dose of Ozempic, for up to a 3-month prescription, for either the pen or the pill. That $25 is subject to a maximum savings of $100 per month, which is the part most summaries leave out: the card covers up to $100 of your monthly cost, so if your plan leaves you owing more than roughly $125, you pay the difference. One month is defined as one box containing one Ozempic pen, or one bottle of 30 tablets. Eligibility and restrictions apply and government beneficiaries are excluded. Full terms are at SavingsCardEligibility.com.
Who is eligible for the Ozempic Savings Card?▼
The $25 offer is for patients with commercial (private or employer) drug insurance and a valid prescription. Government beneficiaries are excluded, and Novo Nordisk states that individuals enrolled in both a commercial and a government-funded plan are treated as government-insured. Novo Nordisk specifically carves out three plan types as NOT government programs for this offer: the Federal Employees Health Benefits (FEHB) Program, Affordable Care Act health exchange plans, and insurance provided through state employee plans. Patients who are enrolled in government programs are directed to the self-pay price instead. The offer operates outside of any third-party insurance, so what you save does not count toward your deductible or out-of-pocket maximum and cannot be submitted to your insurer for reimbursement.
What is the list price of Ozempic?▼
NovoCare publishes a list price of $1,027.51 for each Ozempic package: the 0.25 or 0.5 mg pen (1 x 1.5-mL), the 1 mg pen (1 x 3-mL), the 2 mg pen (1 x 3-mL), and the 1.5 mg, 4 mg, and 9 mg tablets. Novo Nordisk defines list price as the original price set by the manufacturer before any discounts or rebates, and states that most people with health insurance do not pay it. The same NovoCare page also renders $997.58 for those identical packages in its mobile layout, so treat roughly $1,000 per month as the list-price ballpark and read the current figure on the page yourself.
Is Ozempic approved for weight loss?▼
No. Per the FDA label on DailyMed, Ozempic is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. Weight loss is not an approved indication for any Ozempic product, so prescribing it for weight management is off-label. Wegovy is the semaglutide brand FDA-approved for chronic weight management. This matters for cost because coverage, savings-card terms, and manufacturer self-pay programs are all built around the approved use.
Will my insurance cover Ozempic?▼
It depends on your plan and, in practice, on your diagnosis. Ozempic is approved for type 2 diabetes, so plans that cover it generally build their rules around that indication, and many require prior authorization. Novo Nordisk runs a coverage checker on NovoCare that tells you whether your plan covers Ozempic and gives an estimated cost. If you are seeking semaglutide for weight management rather than diabetes, the on-label product is Wegovy, and weight-management coverage is a separate question from diabetes coverage under most plans. Check your specific plan rather than relying on a general answer.
Is there a cheaper way to get semaglutide than Ozempic?▼
Possibly, depending on why you need it. If the goal is weight management, Wegovy is the on-label semaglutide product and has its own NovoCare self-pay pricing. If the goal is diabetes control, the Ozempic pill self-pay price of $149 per month for the 1.5 mg dose is currently the lowest published Ozempic number, well below the $349 to $499 per month steady-state pen price. Novo Nordisk also runs a Patient Assistance Program that provides free medicine to those who qualify, with no registration or monthly fees. Beyond that, cash-pay clinic programs and compounded semaglutide are separate markets with their own tradeoffs, covered in our semaglutide cost and compounded semaglutide guides.
Medical & Pricing Disclaimer
This guide is for general informational purposes only and is not medical advice. We are not affiliated with Novo Nordisk, NovoCare, or NovoCare Pharmacy. Ozempic is a prescription medication FDA-approved for adults with type 2 diabetes; it is not approved for weight loss. Nothing here is dosing guidance, and no outcome is promised. All prices and program terms were read from Novo Nordisk's published pages on August 21, 2026; savings and self-pay offers carry eligibility requirements and restrictions, Novo Nordisk reserves the right to modify or cancel them at any time, and the self-pay pen offer is stated as limited-time with pricing to be updated after December 31, 2026. Verify the current price and full terms directly with NovoCare and your pharmacy before you fill, and decide with a licensed clinician. VitalityScout may earn a commission from some links, at no additional cost to you, and this never affects how we describe a provider.
Sources & References
- • NovoCare — Ozempic list price explained ($1,027.51 per package; $997.58 in the mobile layout; list-price definition)
- • NovoCare — Ozempic savings offer ($25 with commercial insurance, $100/month savings cap, eligibility carve-outs, deductible language)
- • Ozempic.com — Ozempic cost and insurance coverage (per-dose self-pay pricing for pen and pill)
- • NovoCare Pharmacy — self-pay starting prices (Ozempic pill from $149/month, pen from $199/month; December 31, 2026 offer window)
- • DailyMed — OZEMPIC (semaglutide) injection label (indications; Novo Nordisk Pharmaceutical Industries LP; revised 5/2026)
- • DailyMed — OZEMPIC / RYBELSUS oral semaglutide tablet label (tablet indications; not substitutable mg-to-mg)
- • DailyMed — WEGOVY (semaglutide) label (chronic weight-management indications; revised 6/2026)
- • Novo Nordisk — Ozempic pill US availability announcement (US availability May 4, 2026; self-pay $149 / $199 / $299 by dose; type 2 diabetes indication)
- • NovoCare — Novo Nordisk Patient Assistance Program (free medicine for those who qualify)